Research Topics
| D G BostwickSummaryAffiliation: Bostwick Laboratories Country: USA Publications
| Collaborators
|
Detail Information
Publications
Precursors of prostate cancerDavid G Bostwick
Bostwick Laboratories, Glen Allen, VA 23060, USA
Histopathology 60:4-27. 2012..Multiple clinical trials to date of men with PIN have had modest success in delaying or preventing subsequent cancer...
Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapyD G Bostwick
Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA
Urol Clin North Am 26:465-79. 1999..Pathologists must be aware of these distinct changes because of the reliance placed on nuclear and nucleolar size in the identification of prostate cancer, particularly in small specimens and lymph node metastases...
Diagnosis and grading of bladder cancer and associated lesionsD G Bostwick
Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA
Urol Clin North Am 26:493-507. 1999..Uniformity of pathologic reporting should improve the comparability of different studies and therapies and provide more accurate information to urologists in managing patients...
Diagnosis and classification of renal cell carcinomaD G Bostwick
Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA
Urol Clin North Am 26:627-35. 1999....
High-grade prostatic intraepithelial neoplasiaDavid G Bostwick
Bostwick Laboratories, Richmond, VA 23294, USA
Mod Pathol 17:360-79. 2004..Androgen deprivation therapy decreases the prevalence and extent of PIN, suggesting that this form of treatment may play a role in chemoprevention...
Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 casesDavid G Bostwick
Bostwick Laboratories, Richmond, Virginia 23294, USA
Prostate 58:164-8. 2004..The purpose of this study was to compare the expression of AMP in benign prostatic epithelium, high-grade prostatic intraepithelial neoplasia (PIN), and adenocarcinoma...
Contemporary pathology of prostate cancerDavid G Bostwick
Bostwick Laboratories, 2807 North Parham Road, Suite 114, Richmond, VA 23294, USA
Urol Clin North Am 30:181-207. 2003..Numerous findings have proven to be of value, including simple quantitation of histopathologic features, cancer volume, perineural invasion, and others...
Urothelial papillary (exophytic) neoplasmsDavid G Bostwick
Bostwick Laboratories, 2807 N Parham Rd Richmond, VA 23294, USA
Virchows Arch 441:109-16. 2002..Some pathologists may prefer additionally to report synonymous classification in other schemes, but this is discouraged owing to variations and difficulties in translations...
Prostatic intraepithelial neoplasiaD G Bostwick
Bostwick Laboratories, 6722 Patterson Avenue, Richmond, VA 23226, USA
Curr Urol Rep 1:65-70. 2000..Androgen deprivation therapy decreases the prevalence and extent of PIN, suggesting that this form of treatment may play a role in chemoprevention...
Effect of androgen deprivation therapy on prostatic intraepithelial neoplasiaD G Bostwick
Bostwick Laboratories, Richmond, Virginia 23294, USA
Urology 58:91-3. 2001..Multiple chemoprevention trials are planned or under way to address this hypothesis...
Prediction of individual patient outcome in cancer: comparison of artificial neural networks and Kaplan--Meier methodsD G Bostwick
Bostwick Laboratories, Richmond, Virginia 23294, USA
Cancer 91:1643-6. 2001..There is a great need for accurate treatment and outcome prediction in cancer. Two methods for prediction, artificial neural networks and Kaplan--Meier plots, have not, to the authors' knowledge, been compared previously...
Over-diagnosis of high-grade prostatic intraepithelial neoplasia: a prospective study of 251 casesDavid G Bostwick
Bostwick Laboratories, Richmond, Virginia, USA
BJU Int 100:1036-9. 2007..To assess the magnitude and causes of over-diagnosis of prostatic intraepithelial neoplasia (PIN), as large differences are reported in the incidence of high-grade PIN, probably because of the variance in diagnosis and interpretation...
Immunohistochemical changes in prostate cancer after androgen deprivation therapyD G Bostwick
Bostwick Laboratories, Richmond, Virginia 23294, USA
Mol Urol 4:101-6;discussion 107. 2000..This report summarizes the existing literature regarding changes in tissue expression of proteins, as determined by immunohistochemistry, and the clinical implications of these changes...
Phyllodes tumor of the prostate: long-term followup study of 23 casesDavid G Bostwick
Bostwick Laboratories, 2807 North Parham Road, Richmond, VA 23294, USA
J Urol 172:894-9. 2004..Phyllodes tumor of the prostate is a rare neoplasm of uncertain malignant potential. We studied a large series of phyllodes tumors to define the combination of histological features that are most useful for predicting patient outcome...
Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinomaDavid G Bostwick
Bostwick Laboratories, Glen Allen, VA 23060, USA
Hum Pathol 38:1394-401. 2007..We hypothesize that carcinogenesis in the prostate results from impaired cellular handling of mutagenic agents owing to reduction or loss of expression of multiple GST and other detoxifying and antimutagenesis agents...
Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006David G Bostwick
Bostwick Laboratories, Richmond, Virginia 23060, USA
Urology 70:42-4. 2007
Prostatic stromal hyperplasia with atypia: follow-up study of 18 casesDeloar Hossain
Bostwick Laboratories, Glen Allen, VA 23060, USA
Arch Pathol Lab Med 132:1729-33. 2008..Prostatic stromal hyperplasia with atypia is a rare lesion that can be mistaken for sarcoma because of the presence of atypical, bizarre, degenerative myocyte nuclei...
'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 casesDavid G Bostwick
Mayo Clinic, Rochester, Minnesota, USA
BJU Int 94:57-8. 2004..To determine the incidence and long-term follow-up of the 'vanishing cancer' phenomenon, as complete sampling of some radical prostatectomy (RP) specimens reveals no residual cancer...
Atypical small acinar proliferation in the prostate: clinical significance in 2006David G Bostwick
Bostwick Laboratories, Richmond, VA 23060, USA
Arch Pathol Lab Med 130:952-7. 2006..Identification of atypical small acinar proliferation warrants repeat biopsy for concurrent or subsequent invasive carcinoma...
Does finasteride alter the pathology of the prostate and cancer grading?David G Bostwick
Bostwick Laboratories, Richmond, VA 23294, USA
Clin Prostate Cancer 2:228-35. 2004..Chemoprevention trials with agents such as finasteride that alter morphology should not rely on cancer grading as a secondary endpoint owing to grading bias...
Human prostate cancer risk factorsDavid G Bostwick
Bostwick Laboratories, Richmond, Virginia 23294, USA
Cancer 101:2371-490. 2004..An understanding of the risk factors for prostate cancer has practical importance for public health research and policy, genetic and nutritional education and chemoprevention, and prevention strategies...
Extranodal extension in lymph node-positive prostate cancerL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Mod Pathol 13:113-8. 2000..In contrast, nodal cancer volume was predictive of distant metastasis-free survival and cancer-specific survival...
Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasionL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Cancer 85:2638-47. 1999..Evidence has accumulated that cancers invading the superficial muscle wall (T2a) behave similarly to those invading the deep muscle wall (T2b). Quantitative analysis of the depth of invasion in relation to patient outcome is needed...
Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progressionL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Clin Cancer Res 5:2820-3. 1999..52 and 0.17, respectively). Our data indicate that assessment of cell proliferation in nodal metastasis is predictive of clinical outcome in prostate cancer patients with regional lymph node metastasis...
Diagnosis of prostate cancer in needle biopsies after radiation therapyL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Am J Surg Pathol 23:1173-83. 1999..Conversely, Gleason grade in postirradiation needle biopsy specimens appeared to provide useful predictive information and should be reported...
Predictors of cancer progression in T1a prostate adenocarcinomaL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Cancer 85:1300-4. 1999..In the current study the authors attempted to identify such predictors of cancer progression in a large series of untreated patients with lengthy follow-up...
Mutation and expression analysis of the p73 gene in prostate cancerA Yokomizo
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
Prostate 39:94-100. 1999..Recently, p73, a first homologue of p53, was identified and considered to be an imprinted tumor suppressor gene. Thus, we analyzed the possible role of p73 in human prostate cancers...
Risk of prostate carcinoma death in patients with lymph node metastasisL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Cancer 91:66-73. 2001..Results of published reports on survival among patients with lymph node metastasis are difficult to assess because of treatment selections. The extent to which lymph node status will have an impact on a patient's survival is uncertain...
Paraganglioma of the urinary bladder: can biologic potential be predicted?L Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Cancer 88:844-52. 2000..Paraganglioma of the urinary bladder is rarely encountered and its biologic behavior is uncertain. The authors sought to determine the prognostic factors that would predict patient outcome...
The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapyL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Clin Cancer Res 6:1896-9. 2000..06 and 0.01, respectively). These findings indicate that p21 and p27 expression levels are significant predictors of survival for patients selected for salvage prostatectomy for recurrent prostate cancer...
Squamous papilloma of the urinary tract is unrelated to condyloma acuminataL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Cancer 88:1679-86. 2000..To the authors' knowledge, there is no previous report of squamous papilloma of the urinary tract. It is uncertain whether there is a correlation between squamous papilloma, condyloma acuminatum, and verrucous carcinoma...
Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion?L Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Cancer 88:853-61. 2000..Nephrogenic metaplasia with cytologic atypia (atypical nephrogenic metaplasia) is occasionally encountered and its biologic potential is uncertain...
Predicting the survival of bladder carcinoma patients treated with radical cystectomyL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Cancer 88:2326-32. 2000..Clinical outcomes vary for patients treated with radical cystectomy. The authors sought to identify factors associated with the survival of patients treated with radical cystectomy for urothelial carcinoma of the urinary bladder...
Predicting cancer progression in patients with stage T1 bladder carcinomaL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
J Clin Oncol 17:3182-7. 1999..We sought to identify factors associated with cancer progression in a series of patients with stage T1 bladder carcinoma treated with a contemporary therapeutic approach...
Staging prostate cancer--1997: current methods and limitationsD G Bostwick
Department of Pathology, Mayo Clinic, Rochester, MN 55905, USA
Eur Urol 32:2-14. 1997..Recent international agreement on the pathologic staging of prostate cancer should allow valid comparisons of surgical treatment from different institutions...
Conserved genetic findings in metastatic bladder cancer: a possible utility of allelic loss of chromosomes 9p21 and 17p13 in diagnosisL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Arch Pathol Lab Med 125:1197-9. 2001..Molecular analysis of microsatellite alterations of biologically distinct tumor cell subpopulations from the same patient may aid in the determination of tumor origin and further our understanding of the genetic basis of cancer progression...
Natural history of urothelial dysplasia of the bladderL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Am J Surg Pathol 23:443-7. 1999..The authors conclude that urothelial dysplasia is a significant risk for the development of CIS and invasive urothelial carcinoma, and patients with urothelial dysplasia should be followed up closely...
Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomasL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202, USA
Am J Surg Pathol 25:1231-6. 2001..The coexistence of tumor subclones with morphologic heterogeneity can lead to the formation of a clinically detectable tumor...
Reversibility of prostatic intraepithelial neoplasia: implications for chemopreventionD G Bostwick
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn 55905, USA
Eur Urol 35:492-5. 1999..Androgen deprivation therapy and radiation therapy decrease its prevalence and extent, suggesting a role in chemoprevention...
Urothelial papilloma of the bladder. Clinical and biologic implicationsL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Cancer 86:2098-101. 1999..An international consensus has been reached regarding diagnostic criteria for papilloma of the urinary bladder. However, the incidences of recurrence and progression in patients with urothelial papilloma are uncertain...
Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferationK A Iczkowski
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Arch Pathol Lab Med 124:98-107. 2000..We previously described the diagnostic category called atypical small acinar proliferation (ASAP), suspicious for but not diagnostic of malignancy, present in about 2.5% of routine prostatic needle biopsy specimens...
High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancerJ W Aquilina
Mayo Clinic, Rochester, Minnesota 55905, USA
Prostate 36:189-93. 1998..This method will provide important data to determine whether a model of spontaneous PIN in elderly dogs may have clinical utility in developing strategies directed toward preventing and treating prostate...
Cancer heterogeneity and its biologic implications in the grading of urothelial carcinomaL Cheng
Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
Cancer 88:1663-70. 2000..Urothelial carcinoma of the bladder often contains areas with different histologic grades. The influence of cancer heterogeneity on grading and its relation to patient outcome is uncertain...
Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6Neil A Abrahams
Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA
Am J Clin Pathol 120:368-76. 2003..CK5/6 staining of the basal cells in foci of atrophy is sensitive and specific for excluding prostatic adenocarcinoma with and without androgen-deprivation effect...
Steam heat with an EDTA buffer and protease digestion optimizes immunohistochemical expression of basal cell-specific antikeratin 34betaE12 to discriminate cancer in prostatic epitheliumK A Iczkowski
Department of Pathology, Mayo Clinic Rochester, Minnesota 55905, USA
Mod Pathol 12:1-4. 1999..This helps to prevent misinterpretation of histologic mimics of cancer, such as atrophic acini and high-grade prostatic intraepithelial neoplasia, that result from false-negative staining...
Evaluating radical prostatectomy specimens: therapeutic and prognostic importanceD G Bostwick
Department of Pathology, Mayo Clinic, Rochester, MN 55905, USA
Virchows Arch 430:1-16. 1997..Recent international agreement on pathologic staging of prostate cancer should allow valid comparisons of surgical treatment from different institutions. The vanishing cancer phenomenon is also briefly discussed...
Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4W K Lau
Department of Urology, Laboratory Medicine and Pathology, Section of Biostatistics, Mayo Clinic, Rochester, Minnesota 55905, USA
J Urol 166:1692-7. 2001..However, primary Gleason grade does not provide any additional information than other known prognostic factors, such as preoperative PSA, seminal vesicle invasion and DNA ploidy...
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer markerM F Darson
Department of Urology, Mayo Clinic, Rochester, MN 35905, USA
Urology 49:857-62. 1997..We describe the expression of a potentially new tumor marker, human glandular kallikrein 2 (hK2), that may be useful as an adjunct to prostate-specific antigen (PSA) in the diagnosis and monitoring of prostate cancer...
Human acid ceramidase is overexpressed but not mutated in prostate cancerR S Seelan
Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
Genes Chromosomes Cancer 29:137-46. 2000..These results suggest that acid ceramidase may play an important role in prostate carcinogenesis...
Androgen deprivation therapy for precancerous lesions of the prostateDavid Hull
Bostwick Laboratories Inc, Glen Allen, VA 23060, USA
Best Pract Res Clin Endocrinol Metab 22:285-91. 2008....
Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007Isabelle Meiers
Bostwick Laboratories, Glen Allen, Virginia 23060, USA
Urology 70:3-8. 2007..This article reviews the importance of multifocal prostate cancer and the application of focal treatment...
Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancerGirish Venkataraman
Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153, USA
Prostate 67:1524-36. 2007..Prostate needle biopsy (PNB) ploidy status has proven utility to predict adverse outcomes after prostatectomy. We sought to develop models to predict ploidy status using clinicopathologic variables...
Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasisJ Jiang
Department of Pathology, Indiana University School of Medicine, Indianapolis, Ind. 46202, USA
Arch Pathol Lab Med 125:921-3. 2001..All cases showed positive CK7 immunoreactivity in the primary cancers and matched lymph node metastases. CONCLUSIONS:-CK20 immunoreactivity is reliably observed in metastases from bladder cancer when the primary tumor expresses CK20...
Prostate cancer detected by uPM3: radical prostatectomy findingsDavid G Bostwick
Bostwick Laboratories, Glen Allen, VA 23060, USA
Mod Pathol 19:630-3. 2006..The uPM3 is an independent and specific biomarker that detects prostate cancers of similar volume, location, extent and grade as other tests for early detection. uPM3 does not preferentially identify large or aggressive prostate cancers...
Diagnosis of prostatic carcinoma after therapyDavid G Bostwick
Bostwick Laboratories, 4355 Innslake Dr, Glen Allen, VA 23060, USA
Arch Pathol Lab Med 131:360-71. 2007..Treatment changes in the benign and cancerous prostate create diagnostic challenges in pathologic interpretation, particularly in needle biopsy specimens and in evaluation of extraprostatic metastases...
Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridizationJunqi Qian
Bostwick Laboratories, 4355 Innslake Drive, Glen Allen, VA 23060, USA
Cancer Cytopathol 118:97-104. 2010..The authors sought to investigate the utility of chromosomal anomalies for the detection of endometrial hyperplasia and carcinoma using multitarget fluorescence in situ hybridization (FISH)...
Corpora amylacea in adenocarcinoma of the prostate: incidence and histology within needle core biopsiesJames D Christian
Bostwick Laboratories, Richmond, VA 23294, USA
Mod Pathol 18:36-9. 2005..Our results indicate that the incidence of corpora amylacea in adenocarcinoma is low, but the presence of such inclusions cannot be used to exclude malignancy...
Characterization of prostate cancer in needle biopsy by cathepsin B, cell proliferation and DNA ploidyJunqi Qian
Bostwick Laboratories, 4355 Innslake Drive, Glen Allen, VA 23060, USA
Anticancer Res 30:719-25. 2010....
Prostatic leiomyoma with atypia: follow-up study of 10 casesDeloar Hossain
Bostwick Laboratories, Glen Allen, VA 023060, USA
Ann Diagn Pathol 12:328-32. 2008..Four local recurrences were seen, with a follow-up for 3 to 16 years (mean, 7.4 years), but no evidence of sarcomatous transformation occurred. Despite worrisome histologic appearance, a benign clinical behavior was seen in all cases...
Prostate cancer outcome: epidemiology and biostatisticsHarry B Burke
Bostwick Laboratories, Richmond, Virginia, USA
Anal Quant Cytol Histol 27:211-7. 2005..We must implement statistical approaches that integrate the new molecular biomarkers with existing prognostic biomarkers to accurately predict which patients require treatment and to determine the optimal therapy...
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progressionJunqi Qian
Department of Laboratory Medicine and Pathology, Section of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
Mod Pathol 15:35-44. 2002....
Workgroup I: rodent models of prostate cancerM S Lucia
Department of Pathology, University of Colorado, Denver, USA
Prostate 36:49-55. 1998
Overexpression of the wild type p73 gene in human bladder cancerA Yokomizo
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55095, USA
Oncogene 18:1629-33. 1999..These data suggest that the p73 is unlikely to be a tumor suppressor gene, but that overexpression of p73 may contribute to tumorigenesis in bladder cancer...
Fast liquid ablation system for prostatic hyperplasia: a new minimally invasive thermal treatmentAlberto G Corica
Bostwick Laboratories, 2807 North Parham Road, Richmond, VA 23294, USA
J Urol 170:874-8. 2003....
Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 casesDavid Hull
Bostwick Laboratories, Glen Allen, VA 23060, USA
BJU Int 104:915-8. 2009....
High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practiceCory Schlesinger
Bostwick Laboratories, Richmond, VA, USA
Am J Surg Pathol 29:1201-7. 2005....
Mesonephric remnants of the prostate: incidence and histologic spectrumDavid G Bostwick
Bostwick Laboratories, Richmond, Virginia 23294, USA
Mod Pathol 16:630-5. 2003..Immunohistochemical studies with antibodies to PSA and keratin 34BE12 are helpful in separating mesonephric remnants from adenocarcinoma, similar to the case of other benign mimics...
Gadolinium-enhanced MRI in the evaluation of minimally invasive treatments of the prostate: correlation with histopathologic findingsBenjamin T Larson
Department of Radiology, Mayo Clinic, Scottsdale, Arizona, USA
Urology 62:900-4. 2003..Gadolinium-enhanced MRI gives the urologist a useful tool to evaluate the effectiveness of new minimally invasive therapies...
Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancerKenneth A Iczkowski
Department of Pathology, University of Colorado Health Science Center, Denver, Colorado 80045, USA
Urology 71:1166-71. 2008..Subtotal gland ablation by minimally invasive therapies such as cryotherapy demands preoperative prediction of unifocal, unilateral, margin-negative, and small volume (less than 0.5 mL) cancer...
Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implicationsBenjamin T Larson
Bostwick Laboratories, 2807 N. Parham Road, Richmond, VA 23294, USA
J Urol 170:12-9. 2003..These procedures have applications for BPH and prostate cancer, although some studies are limited to only 1 disease. CONCLUSIONS: Minimally invasive procedures show promise of a durable replacement for surgical resection...
Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survivalDavid G Bostwick
Bostwick Laboratories, Richmond, USA
J Urol 168:1204-11. 2002..However, neuroendocrine expression was marginally useful for predicting the outcome in patients with node positive prostate cancer treated with radical prostatectomy...
Prostate needle biopsy quality in reduction by dutasteride of prostate cancer events study: worldwide comparison of improvement with investigator training and centralized laboratory processingDavid G Bostwick
Bostwick Laboratories, Glen Allen, Virginia 23060, USA
Urology 75:1406-10. 2010..The accuracy of prostate cancer detection is influenced by the length and number of biopsy cores...
Practical clinical application of predictive factors in prostate cancer. A review with an emphasis on quantitative methods in tissue specimensD G Bostwick
Department of Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
Anal Quant Cytol Histol 20:323-42. 1998....
Intraepithelial and stromal lymphocytes in the normal human prostateDavid G Bostwick
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA
Prostate 55:187-93. 2003..The inverted CD4/CD8 ratio in the intraepithelial compartment suggests that cytotoxic/suppressor T cells are the first line of defense against luminal foreign agents reaching the prostate through retrograde flow...
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trialSteven R Alberts
Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Am J Ther 13:291-7. 2006..Quality-of-life measures did not show any differences between the 2 groups. This study showed no evidence of benefit from flutamide as a chemoprevention agent in men with HGPIN...
Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United StatesEdward M Messing
Department of Urology, University of Rochester Medical Center, Rochester, New York 14642, USA
J Urol 174:1238-41. 2005..We assessed the performance of the ImmunoCyt immunocytochemical test for detecting bladder cancer recurrence in patients with prior superficial bladder cancers compared with cystoscopic and histological findings...
Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosisLina Liu
Bostwick Laboratories, Inc, 4355 Innslake Dr, Glen Allen, VA 23060, USA
Arch Pathol Lab Med 131:1290-7. 2007..The separation of chromophobe renal cell carcinoma, oncocytoma, and clear cell renal cell carcinoma using light microscopy remains problematic in some cases...
Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007Isabelle Meiers
Department of Pathology, Bostwick Laboratories, London, United Kingdom
Pathology 39:299-304. 2007..Inhibition of aberrant promoter methylation could theoretically prevent carcinogenesis...
Improved filter method for urine sediment detection of urothelial carcinoma by fluorescence in situ hybridizationIsabelle Meiers
Bostwick Laboratories, 4355 Innslake Dr, Glen Allen, VA 23060, USA
Arch Pathol Lab Med 131:1574-7. 2007..Fluorescence in situ hybridization (FISH) of voided urine sediment is a sensitive and specific test for the detection of urothelial carcinoma. The time required for slide preparation using the conventional cytospin method is lengthy...
Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumorsGregory T MacLennan
Department of Pathology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH 44106, USA
Clin Lab Med 25:393-416. 2005..Most have been included in the 2004 edition of the WHO classification of tumors of the urinary system and male genital organs. Tubulocystic carcinoma needs to be studied and characterized more fully...
Needle core length in sextant biopsy influences prostate cancer detection rateKenneth A Iczkowski
Department of Pathology and Laboratory Medicine, Veterans Affairs Medical Center, Gainesville, Florida 32608-1197, USA
Urology 59:698-703. 2002..6-fold and represents a quality assurance consideration. The effect of length on cancer or nonbenign detection was maximal at the prostatic apex where the cores were shortest...
Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostateDavid J Waters
Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, IN 47907, USA
J Natl Cancer Inst 95:237-41. 2003..7 (interquartile range = 0.2-2.8) for the control dogs ( P =.04, Mann-Whitney U test). These data suggest that dietary selenium supplementation decreases DNA damage and increases epithelial cell apoptosis within the aging canine prostate...
Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approachGerald L Andriole
Division of Urologic Surgery, Washington University School of Medicine, St Louis, Missouri 63110, USA
Urology 70:22-6. 2007..Its reproducibility from operator to operator suggests that it may be useful for guiding rebiopsy of specific locations within the prostate and for providing targeted focal prostate cancer therapy...
Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapyChristopher L Coogan
Department of Urology, Rush-Presbyterian St. Luke's Medical Center, Chicago, Illinois 60612, USA
Urology 61:248-52. 2003..In particular, A-80 staining of biopsies may be useful in detecting residual and/or recurrent prostate carcinoma after radiation or hormonal therapy...
Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimensAndrew J Evans
Department of Pathology and Laboratory Medicine, University Health Network, Toronto, Ontario, Canada
Am J Surg Pathol 32:1503-12. 2008..Interobserver variability for EPE and SM interpretation was principally related to the lack of a clearly definable prostatic capsule and crush/thermal artifact along the edge of the gland, respectively...
Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trialJ Curtis Nickel
Department of Urology, Queen s University, Kingston General Hospital, Kingston, Ontario, Canada
J Urol 178:896-900; discussion 900-1. 2007..5 mg dutasteride daily decreases the risk of biopsy detectable prostate cancer. All men underwent biopsy before study entry, allowing review of the relationship between histological prostate inflammation and prostatitis symptoms...
Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysisCarolyn J M Best
Pathogenetics Unit, Laboratory of Pathology and Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Diagn Mol Pathol 12:63-70. 2003..We suggest that these data provide insight into the molecular nature of clinically aggressive prostate cancer...
Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostateXiaoyan Wang
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Mod Pathol 20:175-82. 2007..Anti-EGFR and/or antiandrogen agents may be potentially useful for management of patients with tumors expressing EGFR and/or androgen receptor...
Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasiaRodolfo Montironi
Institute of Pathological Anatomy and Histopathology, Polytechnic University of the Marche Region, Ancona, Italy
Mod Pathol 17:928-37. 2004....
Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinomaRodolfo Montironi
Institute of Pathological Anatomy and Histopathology, University of Ancona School of Medicine, Torrette, Italy
Hum Pathol 34:893-901. 2003..In conclusion, karyometry can detect an abnormal chromatin pattern and distribution in the normal-looking urothelium adjacent to papillary carcinoma. Such alterations correspond to the so-called "malignancy-associated change."..
Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostateRyan P McCarthy
Department of Pathology and Laboratory Medicine, Indiana University Medical Center, University Hospital 3465, 550 North University Blvd, Indianapolis, IN 46202, USA
Am J Pathol 165:1395-400. 2004..While both epithelium and stroma are clonal proliferations, they appear to have different clonal origins...
Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissueLeonard S Marks
Department of Urology, University of California, Los Angeles, Geffen School of Medicine, Los Angeles, California, USA
Urology 64:765-71. 2004..Differences in nuclear morphometry suggested the additional possibility of gene-nutrient interactions...
The dual 5-alpha-reductase inhibitor dutasteride induces atrophic changes and decreases relative cancer volume in human prostateKenneth A Iczkowski
Department of Pathology and Laboratory Medicine, Veterans Affairs Medical Center, Gainesville, Florida 32608 1197, USA
Urology 65:76-82. 2005..To perform the first evaluation of the effects of the 5-alpha-reductase inhibitor class of drugs on cancer histopathologic features at radical prostatectomy in a placebo-controlled multicenter trial...
Pleomorphic giant cell carcinoma of the prostateAntonio Lopez-Beltran
Department of Pathology, Cordoba University Medical School, Cordoba, Spain
Arch Pathol Lab Med 129:683-5. 2005..Pleomorphic giant cell carcinoma is a rare variant of prostatic adenocarcinoma with a poor prognosis that should be considered in the differential diagnosis of prostatic pleomorphic tumors...
Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotypeAntonio Lopez-Beltran
Department of Pathology, Cordoba University Medical School, Cordoba, Spain
Int J Surg Pathol 13:167-73. 2005..105) or carcinoma (p=0.0820). All foci of nodular hyperplasia, AAH, and carcinoma were diploid. Ploidy status and our selected panel of antibodies did not discriminate among these 3 entities reliably...
Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimensRodolfo Montironi
Polytechnic University of the Marche Region, School of Medicine, Umberto I Hospital, Torrette, Ancona, Italy
Hum Pathol 36:646-54. 2005..We conclude that incidentally detected cancer is less aggressive than clinically detected cancer...
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialLeonard S Marks
Department of Urology, Geffen School of Medicine, University of California, Los Angeles, USA
JAMA 296:2351-61. 2006..Prostate safety is a primary concern when aging men receive testosterone replacement therapy (TRT), but little information is available regarding the effects of TRT on prostate tissue in men...
Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy")Rodolfo Montironi
Pathology, Marche Polytechnic University, Ancona, Italy
Eur Urol 50:666-74. 2006..To review atypical focus suspicious but not diagnostic of malignancy in needle biopsies of the prostate, also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy."..
Prostate biopsy and optimization of cancer yieldDavid G Bostwick
Eur Urol 49:415-7. 2006
Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancerAkhouri A Sinha
Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA
Exp Mol Pathol 77:153-9. 2004..Our objective was to evaluate microvessel density as a molecular marker for distinguishing HGPINs that have the potential of progressing to cancer...
Ferromagnetic self-regulating reheatable thermal rod implants for in situ tissue ablationJamil Rehman
Department of Surgery, Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
J Endourol 16:523-31. 2002..This form of minimally invasive in situ ablative therapy appears promising. Clinical trials in the kidney and in other abdominal and pelvic organs are pending...
